Skip to content

Clinical trials

Demyelinating Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20153
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.4
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1
MedImmune LLC1
Novartis Pharmaceuticals1
Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases8
Neuromyelitis Optica5
Optic Neuritis5
Myelitis, Transverse4
Recurrence4
Multiple Sclerosis2
Nervous System Diseases2
Autoimmune Diseases1
Brain Diseases1
Brain Diseases, Metabolic, Inborn1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.